Drug firms colluded to raise price of essential NHS medicine by 1,800 per cent, watchdog finds

04 October 2019 – Independent

A conspiracy by three pharmaceutical firms resulted in a huge price hike for a life-saving drug purchased by the NHS, according to provisional findings by the competition watchdog.

In 2016, pharmaceutical giant Aspen made a deal with two other firms to keep them out of the UK market for fludrocortisone according to the Competition and Markets Authority (CMA). Thousands of patients rely on the medicine to treat what is known as Addison’s disease – an insufficient production of certain hormones.

Source

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: